| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |